News Release – For Immediate Release InQ Biosciences to Commercialize Cell Research System in First Quarter 2011 HUNTSVILLE

, ALABAMA, December 13, 2010 — InQ Biosciences, a provider of innovative technologies for cell growth and research, announced today it will commercially release its InQ Cell Research System during the first quarter of 2011. InQ is the first fully integrated system that creates a high-fidelity in vitro environment for studying stem cells –as well as nerve, brain or any other cells that can be grown in a Petri dish for disease research. In an announcement at the 2010 Annual Meeting of the American Society for Cell Biology, the company said it will begin commercial production of the InQ system in early 2011 and will accept orders beginning immediately. “This milestone represents the first cell research application of our InQ technology that promises critical new discoveries in stem cell biology and in the causes and treatment of neurological disorders, cancer, and cardiovascular diseases,” said Aaron Hammons, president and chief technology officer, InQ Biosciences. “By integrating a dynamically controlled sample environment, advanced imaging, and real-time data collection, the InQ system empowers scientists with an exciting new tool that accelerates diagnostic and therapeutic discoveries.” Hammons said InQ technology is the first to offer the following advantages: • High-fidelity simulation of the human body environment, including circadian temperature rhythms and numerous disease states • Precise, automated management of temperature, gas levels, media perfusion, pressure, and waste removal • Automated onboard microscopy for real-time monitoring and analysis • Unprecedented local/remote access and control “Now a researcher can simulate hundreds of disease states and conduct event-based analyses while improving laboratory productivity,” he said. Floyd Presents First InQ Data Dr.Candace Floyd, assistant professor, Department of Physical Medicine and Rehabilitation, University of Alabama at Birmingham, and member of InQ Biosciences Scientific Advisory Board, said her initial experience testing the InQ system showed promising results. “We were able to grow, under tight conditions, various types of cells whose quality is equal to or better than those cultured in a Petri dish,” said Dr. Floyd. “We have confirmed the growth of exceptionally well formed astrocytes and neurons from the brain as well as cardiac myocytes. “With InQ technology, you are able to push the envelope of discovery by having much more precise control over your experiments and a real-time readout of the variables you choose for your cellular biology,” Dr. Floyd said. Dr. Todd McDevitt, associate professor, Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, and member of InQ Biosciences’ Scientific Advisory Board, said the system will significantly enhance stem cell research.

“With InQ, you can perform an experiment where you keep conditions constant, replenish them at high frequency, or even make very rapid changes in the culture environment,” said Dr. McDevitt. “Then you can map the results back to those conditions and get to causality much better than the correlative types of research initially done in cell biology. I think this technology will expedite the entire stem cell research process because scientists can now create fancy constructs,” he said. The InQ system automates the cell culture process by enclosing the cells in a sealed, sterile removable cartridge that slides into the instrument. An onboard computer precisely controls the mix and flow of nutritive media and gasses and regulates the temperature. A built-in high-resolution microscope and camera record the assay and can send the images to the researcher anywhere in the world via the Internet and smart phone. The InQ System fits easily into research workflows and integrates with most laboratory information management systems. For more information on the InQ System, contact info@inqbio.com or 866-735-9684, or visit http://www.inqbio.com. About InQ Biosciences InQ Biosciences is a provider of innovative technologies for cell growth and research. The company’s InQ Cell Research System will empower scientists to unlock novel and more powerful approaches to cell-based discovery. The firm was founded in 2007 with technology originating from the University of Alabama in Huntsville. Series B financing was completed in May 2010 and commercial launch of its InQ system is scheduled for the first quarter of 2011. For more information, visit http://www.inqbio.com. Follow InQ Biosciences on Twitter at http://twitter.com/InQbio. ### Notes to Editors: • Press contact: Don Goncalves, dgoncalves@tizinc.com, 781-793-9380 • High resolution images for publication: http://bit.ly/eSAUhE • Video tour: http://www.inqbio.com/products.php • Follow on Twitter: http://twitter.com/inqbio • Tags: InQ Cell Research System, cell growth

Sign up to vote on this title
UsefulNot useful